ULTIMA GENOMICS H-1B Visa Sponsorship & Salary Data

The median H-1B salary at ULTIMA GENOMICS is $94,786, based on 47 certified filings from FY 2020 to FY 2026. This is 21% lower than the national H-1B median salary of $120,000. Compensation at ULTIMA GENOMICS reflects their market positioning, with entry-level roles starting around $83,699 and senior positions reaching $140,920 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at ULTIMA GENOMICS range from $71,906 at the 10th percentile to $140,920 at the 90th percentile, showing a $69,014 spread across experience levels and roles. The 25th percentile is $83,699 and the 75th percentile is $122,699.

Yes, ULTIMA GENOMICS actively sponsors H-1B visas in FY 2026. In the most recent fiscal year (FY 2026), ULTIMA GENOMICS filed 5 H-1B labor condition applications with 5 certified and 0 denied, at a median salary of $101,629. Across FY 2020–2026, they have filed 53 total H-1B applications with 47 certified and a 0% lifetime denial rate, demonstrating ongoing commitment to hiring international talent. ULTIMA GENOMICS sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2026), ULTIMA GENOMICS filed 5 H-1B applications, with 5 certified and 0 denied. Over 7 years of data, ULTIMA GENOMICS has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

ULTIMA GENOMICS's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 53 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating ULTIMA GENOMICS as a potential H-1B sponsor.

This is an excellent approval rate, indicating ULTIMA GENOMICS has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

ULTIMA GENOMICS sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 47 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles ULTIMA GENOMICS most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at ULTIMA GENOMICS:

The most frequently sponsored role is Field Service Engineer I with 5 filings at a median salary of $73,694. This is followed by Manager, Reagent & Kit Development (4 filings) and Research Scientist.

ULTIMA GENOMICS's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where ULTIMA GENOMICS sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top ULTIMA GENOMICS H-1B locations:

The largest H-1B hub for ULTIMA GENOMICS is Newark, CA with 23 filings at a median salary of $122,283. The highest-paying location is Newark, CA at $122,283 median. Salaries range from $71,906 to $122,283 across office locations.

ULTIMA GENOMICS's median H-1B salary has increased by +21% from FY 2020 ($83,866) to FY 2026 ($101,629). Tracking salary trends over time reveals how ULTIMA GENOMICS adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at ULTIMA GENOMICS.

Year-by-year breakdown:

• FY 2022: $122,283 (13 certified)
• FY 2023: $84,490 (9 certified)
• FY 2024: $83,699 (4 certified)
• FY 2025: $94,786 (7 certified)
• FY 2026: $101,629 (5 certified)

This 21% growth reflects strong compensation adjustments at ULTIMA GENOMICS, keeping pace with market demands for H-1B talent.

ULTIMA GENOMICS primarily files H-1B applications at Wage Level I, accounting for 57% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making ULTIMA GENOMICS's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

A significant portion of ULTIMA GENOMICS's H-1B filings are at entry-level (Level I) wages. These positions may face more competition in the H-1B lottery.

ULTIMA GENOMICS's median H-1B salary of $94,786 is 21% lower than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating ULTIMA GENOMICS's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare ULTIMA GENOMICS's offerings with similar companies in your field for a more accurate assessment.

ULTIMA GENOMICS's H-1B salaries are below the national median, though this may vary significantly by role, experience level, and location. Consider researching specific positions for more accurate compensation expectations.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. ULTIMA GENOMICS files 57% of positions at Level I, which may face more lottery competition under wage-level prioritization rules.

With 47 certified filings, ULTIMA GENOMICS invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.